Stellar Resources Grants 6 Million Performance Rights to Senior Executives Under Employee Incentive Plan

Stellar Resources Issues Performance Rights to Senior Management

Stellar Resources Limited announced the issuance of 6 million performance rights under its employee incentive scheme on 17 July 2026. These rights were allocated to key management personnel and associates as part of the company’s senior executive remuneration framework, bringing the total unquoted performance rights in the SRZAM class to approximately 94.998 million.

Performance rights are unquoted securities that do not trade on the ASX like ordinary shares. They represent conditional entitlements to acquire ordinary shares upon meeting specified performance criteria or vesting milestones. The detailed terms, including vesting schedules and performance hurdles, are outlined in the company’s employee incentive scheme documentation, accessible via ASX regulatory filings for investor reference.

Capital Structure Overview Post-Issuance

Following this issuance, Stellar Resources’ capital structure includes 339.149 million ordinary fully paid shares (SRZ) and an equal number of ordinary fully paid deferred settlement shares (SRZDA), both quoted on the ASX. These constitute the primary equity interests available for public trading.

Additionally, the company holds a substantial portfolio of unquoted securities: 62.5 million options with varied expiry dates and exercise prices (SRZAA class), 10 million options expiring on 13 August 2026 at a $0.03 exercise price (SRZAL class), and approximately 94.998 million performance rights (SRZAM class). This diverse unquoted security base reflects Stellar Resources’ use of equity-based incentives within its capital management and remuneration strategies.

Shareholder Approval Exemption Under ASX Listing Rules

The 6 million performance rights were issued without the need for shareholder approval under ASX Listing Rule 7.1 by relying on exemption 13 within Listing Rule 7.2. This exemption allows companies to issue securities under certain circumstances without breaching the 15% placement limit that would otherwise require shareholder consent. Stellar Resources’ use of this exemption demonstrates adherence to its established regulatory and capital management frameworks.

This regulatory provision recognizes that issuances under approved employee incentive schemes can proceed without direct shareholder ratification, providing operational flexibility while ensuring investor protections through ASX disclosure and reporting requirements. The reliance on exemption 13 confirms that this issuance falls within permitted capital management activities.

Employee Incentive Scheme Governance at Stellar Resources

Stellar Resources’ employee incentive scheme governs the granting of performance rights to eligible participants, including directors, executives, and senior management. The scheme details eligibility, performance conditions, vesting schedules, and treatment upon employment termination. Full terms are available via ASX filings.

Performance-based equity instruments are widely adopted across ASX-listed companies to align management and shareholder interests through long-term incentives. Vesting of performance rights typically depends on achieving financial or operational targets, time-based milestones, or both. The recent grant of 6 million performance rights to key management reinforces Stellar Resources’ commitment to performance-linked executive compensation.

Unquoted Securities Versus Ordinary Shares

The newly issued performance rights are unquoted securities, distinct from the company’s 339.149 million ordinary fully paid shares traded on the ASX. Unlike ordinary shares, unquoted securities lack daily trading liquidity and are subject to specific contractual terms. Performance rights confer conditional rights to ordinary shares upon satisfying vesting conditions rather than immediate ownership.

For investors, understanding the distinction between quoted and unquoted securities is critical. Ordinary shares provide direct economic exposure and voting rights, whereas performance rights represent contingent claims that convert upon vesting. The ratio of performance rights to ordinary shares offers insight into potential dilution and management’s equity participation, aiding in evaluating long-term ownership and incentive alignment.

Options on Issue and Incentive Structure

Alongside performance rights, Stellar Resources holds a significant number of options: 62.5 million (SRZAA class) with varied expiry and exercise prices, and 10 million expiring 13 August 2026 at $0.03 (SRZAL class). These options grant holders the right to acquire ordinary shares at predetermined prices within specified periods.

The coexistence of multiple option and performance right classes indicates a layered equity incentive approach. Different tranches may correspond to various grant dates, schemes, or participant groups. The total unquoted securities—approximately 95 million performance rights and 72.5 million options—represent a substantial contingent claim on future ordinary shares. Investors should track the SRZAL options expiry and performance rights vesting schedules to assess potential dilution.

Regulatory Disclosure and Transparency

Stellar Resources disclosed the performance rights issuance via the Appendix 3G form, fulfilling ASX continuous disclosure obligations. This formal notification provides detailed information on the issuance date, recipients, and terms, ensuring market transparency.

The company also provided access to its employee incentive scheme documentation through ASX filings, enabling investors to review the governance framework and specific conditions governing the performance rights. This transparency supports informed investment decisions by clarifying vesting criteria, performance hurdles, change of control provisions, and other key terms.

Deferred Settlement Shares and Capital Base

Stellar Resources has 339.149 million ordinary fully paid deferred settlement shares (SRZDA), matching the number of ordinary fully paid shares (SRZ) outstanding. Deferred settlement shares typically arise from transactions where share purchase settlement occurs at a future date. This structure may reflect prior capital raisings or placements.

From an investor perspective, deferred settlement shares are economically equivalent to ordinary shares once settled. The equal quantity of ordinary and deferred settlement shares suggests a specific historical transaction arrangement. Understanding any settlement timing or risk is important for assessing the company’s fully paid capital and potential dilution upon settlement completion.

Investor Considerations Post-Issuance

Following this performance rights issuance, investors should monitor key factors including the disclosure of vesting conditions and performance hurdles that govern conversion into ordinary shares. Additionally, tracking operational or financial milestones linked to vesting and the expiry of SRZAL options on 13 August 2026 is critical.

Investors should also evaluate the cumulative dilution risk from all unquoted securities. With roughly 95 million performance rights and 72.5 million options outstanding, full vesting and exercise could significantly dilute existing shareholders. Understanding the company’s rationale, vesting timelines, and expected exercise rates will aid in assessing long-term shareholder value and capital structure dynamics.